The Scientific Research and Development team at Interpace Biosciences focuses on pioneering and enhancing molecular diagnostic tests that assess cancer risks. Leveraging expertise in pathology and clinical assay development, team members collaborate to innovate, validate, and refine diagnostic technologies, ensuring they meet clinical needs and regulatory standards. Their work is crucial in advancing the company's mission to provide accurate and effective cancer risk evaluation tools.
View all